Yap, D. Y. H., Tang, C., Fung, J. Y. Y., Seto, W., Ma, M. K. M., Choy, B. Y., & Chan, T. M. (2019). Long‐term data on entecavir treatment for treatment‐naive or lamivudine‐resistant chronic hepatitis B infection in kidney transplant recipients. Transplant infectious disease, 21(5), e13143-n/a. https://doi.org/10.1111/tid.13143
Chicago Style (17th ed.) CitationYap, Desmond Y. H., Colin Tang, James Y. Y. Fung, Wai‐Kay Seto, Maggie K. M. Ma, Bo Ying Choy, and Tak Mao Chan. "Long‐term Data on Entecavir Treatment for Treatment‐naive or Lamivudine‐resistant Chronic Hepatitis B Infection in Kidney Transplant Recipients." Transplant Infectious Disease 21, no. 5 (2019): e13143-n/a. https://doi.org/10.1111/tid.13143.
MLA (9th ed.) CitationYap, Desmond Y. H., et al. "Long‐term Data on Entecavir Treatment for Treatment‐naive or Lamivudine‐resistant Chronic Hepatitis B Infection in Kidney Transplant Recipients." Transplant Infectious Disease, vol. 21, no. 5, 2019, pp. e13143-n/a, https://doi.org/10.1111/tid.13143.